DBD: Adjustment of the investment project

On September 12, 2018, the BOD of Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company approved to adjust the investment project of Bidiphar High Technology Company Limited at Nhon Hoi as follows:

1. Investment object:  to invest and build a new high tech pharmaceuticals production Plant for the Group of drugs for cancer treatment with GMP PICs standards and solid oral medication Non-Betalactam with GMP – EU standards.
2. Capacity scale:

-          Group of drugs for cancer treatment: 3.5 million products/year (equivalent to 10 tons/year)

-          Group of solid oral medication Non-Betalactam: 1.3 billion products/year (equivalent to 1,300 tons/year)

-          Area: 20,003 m³

1. Project implementation progress:

-          Q4.2019:  to finish the operation of the cancer drug manufacturing plant.

Q4.2020: to finish the operation of the solid oral medication Non-Betalactam manufacturing plant.

HOSE

>   MTG: Decision on solving administrative taxation violations (14/09/2018)

>   MSR: Change in outstanding shares with voting rights (14/09/2018)

>   E1VFVN30: Tracking error from 07 Sep 2018 to 13 Sep 2018 (14/09/2018)

>   E1VFVN30: Announcement after exchange trading 13 Sep 2018 (14/09/2018)

>   E1VFVN30: NAV 13 Sep 2018 (14/09/2018)

>   E1VFVN30: NAV week from 07 Sep 2018 to 13 Sep 2018 (14/09/2018)

>   NKG: Transferring company model of Nam Kim Corea (14/09/2018)

>   Điểm tin giao dịch 14.09.2018 (14/09/2018)

>   Market Summary 14.09.2018 (14/09/2018)

>   VPB: Notice of trading of shares by an internal shareholder (14/09/2018)